CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $480,338 | +230.1% | 17,634 | +169.7% | 0.00% | – |
| Q2 2023 | $145,522 | -34.5% | 6,539 | -36.2% | 0.00% | – |
| Q1 2023 | $222,022 | +57.5% | 10,251 | +47.9% | 0.00% | – |
| Q4 2022 | $141,000 | -0.7% | 6,933 | +24.9% | 0.00% | – |
| Q3 2022 | $142,000 | +21.4% | 5,551 | +16.4% | 0.00% | – |
| Q2 2022 | $117,000 | +254.5% | 4,770 | +24.0% | 0.00% | – |
| Q1 2022 | $33,000 | -52.9% | 3,847 | +10.4% | 0.00% | – |
| Q4 2021 | $70,000 | -43.5% | 3,485 | -44.2% | 0.00% | – |
| Q3 2021 | $124,000 | -11.4% | 6,242 | -1.0% | 0.00% | – |
| Q2 2021 | $140,000 | -51.0% | 6,303 | -46.1% | 0.00% | -100.0% |
| Q1 2021 | $286,000 | -6.5% | 11,698 | -0.2% | 0.00% | 0.0% |
| Q4 2020 | $306,000 | +1510.5% | 11,722 | +922.9% | 0.00% | – |
| Q3 2020 | $19,000 | +26.7% | 1,146 | +27.6% | 0.00% | – |
| Q2 2020 | $15,000 | +7.1% | 898 | -20.4% | 0.00% | – |
| Q1 2020 | $14,000 | – | 1,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |